Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
CPSC Recall1 injuries · 2025-12-18 · 26157
Hazards
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Recall
Number
26157
Date
2025-12-18
Injuries reported
1
Products
Names
Mamisan Pain Relieving Topical Ointment
Remedies
Options
Repair
Companies
Manufacturer(s)
MiramarLab, of Doral, Florida
Retailer(s)
Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
Distributor(s)
Plantimex Distributors, Inc., of San Diego, California
Country of manufacture
United States
Description
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.